Prediction of Survival Benefit of Filgrastim in Adult and Pediatric Patients With Acute Radiation Syndrome
Acute exposure to high doses of radiation leads to severe myelosuppression, but few treatments are currently available to treat hematopoietic syndrome of acute radiation syndrome. Granulocyte colony stimulating factors (e.g., filgrastim) stimulate proliferation of neutrophil precursors and enhance m...
Saved in:
Main Authors: | John Harrold (Author), Per Olsson Gisleskog (Author), Juan Jose Perez‐Ruixo (Author), Isabelle Delor (Author), Andrew Chow (Author), Philippe Jacqmin (Author), Murad Melhem (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar
by: Schwartzberg LS, et al.
Published: (2018) -
An exposure‐response analysis of ponesimod clinical efficacy in a randomized phase III study in patients with relapsing multiple sclerosis
by: Belén Valenzuela, et al.
Published: (2022) -
EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN
by: A.A. Maschan, et al.
Published: (2010) -
EFFECTIVENESS AND SAFETY OF FILGRASTIM BIOANALOGUE IN TREATMENT AND PROPHYLAXIS OF GRANULOCYTOPENIA IN CHILDREN
by: A.A. Maschan, et al.
Published: (2010) -
Efficacy and safety of peg-filgrastim as primary prophylaxis following pediatric dose-intensive chemotherapy: A randomized controlled trial
by: Jagdish Prasad Meena, et al.
Published: (2024)